InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,282.72
(
-0.27%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,895.35
(
-0.49%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

guardiangel

Send PM Follow Ignore
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

guardiangel

Re: dcspka post# 26392

Tuesday, 11/25/2014 1:15:29 AM

Tuesday, November 25, 2014 1:15:29 AM

Post# of 30046
http://www.flinnfoundation.com/bio-briefs/2784

https://www.fundable.com/the-lung-cancer-test

Jul 13, 2010

Radient Pharmaceutical buying Provista Diagnostics
Tags: cancer, neuroscience

[Source: Phoenix Busines Journal] - Provista Diagnostics Inc., a Phoenix biotech company marketing blood tests for breast cancer and other diseases, has signed a letter of intent to be acquired by Radient Pharmaceutical Corp. of California

Radient announced today its intent to acquire Provista in a stock-for-stock transaction. Provista has rights, patents and trademarks for diagnostic technologies that Radient believes will strengthen and complement its core business.

For more information: Radient Pharmaceutical buying Provista Diagnostics
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up